News

Video

Biomarker Testing in Biliary Tract Cancers: The Role of Liquid Biopsy

Related Videos
Anthony M. Hunter, MD
Thomas Westbrook, MD, assistant professor, Department of Internal Medicine, Rush University
John K. Lee, MD, PhD, associate professor-in-residence, Division of Hematology/Oncology, Department of Medicine; the Institute for Urologic Oncology, Department of Urology, the David Geffen School of Medicine, UCLA Heath
Tae Min Kim, MD, PhD
Whitney Goldsberry, MD
Syed Abbas Ali, MBBS
Farrukh Awan, MD
Related Content
FDA
January 16th 2025

Lete-Cel Receives FDA Breakthrough Therapy Designation for Advanced Myxoid/Round Cell Liposarcoma

MedNews Week Advances Global Oncology Education and Combats Misinformation: With Chandler Park, MD; and Yan Leyfman, MD
January 15th 2025

MedNews Week Advances Global Oncology Education and Combats Misinformation: With Chandler Park, MD; and Yan Leyfman, MD

US FDA
January 16th 2025

Tabelecleucel BLA Receives FDA CRL in Pretreated EBV+ Post-Transplant Lymphoproliferative Disease

Oncology PER® Spectives™: PSMA in Prostate Cancer: Precision Medicine in Imaging & Therapy
January 14th 2025

Oncology PER® Spectives™: PSMA in Prostate Cancer: Precision Medicine in Imaging & Therapy

OST-HER2 in lung-only metastatic osteosarcoma | Image Credit: © 2rogan - stock.adobe.com
January 16th 2025

OST-HER2 Meets Primary End Point of Phase 2b Trial in Lung-Only Metastatic Osteosarcoma

Martin Dreyling, MD, PhD
January 16th 2025

Addition of ASCT to Ibrutinib Plus Rituximab Does Not Confer Benefit in Lower-Risk, Younger MCL